Monthly Archives: February 2016

International Hypertension Program Launch

Medical Device clinical study in treatment of uncontrolled hypertension – an international program launch AmeRuss recently executed an agreement with a medical device firm within  an international consortium of companies to conduct a clinical trial in patients with uncontrolled hypertension. The 2 year study will combine efforts of sites in Russia, Belgium, Germany, Hungary, Ireland, Israel,...

Phase III study – Acute Bronchitis submitted for approval in Russia

A randomized prospective comparative, open, parallel group clinical study of the efficacy and safety of film-coated pills and oral solution of investigational drug in adults with acute bronchitis has recently been submitted to the Russian Ministry of Health for approval. AmeRuss is providing full-service regulatory and investigational support including performance of all necessary regulatory activities, submissions...

Interim analysis enrollment target reached on time in Phase II breast cancer study

AmeRuss is happy to announce that the global enrollment of the study of approved combination of study drugs for the treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer which has progressed following prior therapy reached its interim analysis milestone on time. This is an open label, randomized, multicenter, phase II study...